Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial

Olivier Sitbon, Jaume Bosch, Emmanuelle Cottreel, Denes Csonka, Pascal de Groote, Marius M. Hoeper, Nick H. Kim, Nicolas Martin, Laurent Savale, Michael Krowka

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences